(Q37339933)

19 August 2017

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate tablets (English)

1 reference

19 August 2017

1 reference

1 reference

Dennis J Cada

1

1 reference

19 August 2017

Silvia Torres

series ordinal

2

1 reference

19 August 2017

Terri L Levien

series ordinal

3

1 reference

19 August 2017

Danial E Baker

series ordinal

4

1 reference

19 August 2017

1 January 2013

1 reference

19 August 2017

1 reference

19 August 2017

48

1 reference

19 August 2017

1

1 reference

19 August 2017

48-56

1 reference

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3839433

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3839433

Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3839433

Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3839433

2 September 2018

Identifiers

DOI

10.1310/HPJ4801-48

1 reference

19 August 2017

1 reference

19 August 2017

1 reference